Results 81 to 90 of about 10,110 (220)

DataSheet_3_Ketoconazole as second-line treatment for Cushing’s disease after transsphenoidal surgery: systematic review and meta-analysis.docx

open access: yes, 2023
IntroductionThe first-line treatment for Cushing’s disease is transsphenoidal surgery for pituitary tumor resection. Ketoconazole has been used as a second-line drug despite limited data on its safety and efficacy for this purpose.
Camila Viecceli (15424091)   +11 more
core   +1 more source

Long-Term Outcomes and Recurrence of Rathke’s Cleft Cysts Post Endoscopic Endonasal Resection

open access: yesBrain Science Advances
Background: Rathke’s cleft cysts (RCCs) are benign sellar and suprasellar lesions. Most are treated conservatively, while others require surgery, usually via a transsphenoidal intervention.
Wareef W. AlGhamdi   +8 more
doaj   +1 more source

Management strategies of intercavernous sinus bleeding during transsphenoidal surgery

open access: yes, 2009
BACKGROUND: Transsphenoidal surgery has been well established as an effective primary treatment for tumours of the sellar region. During the dural opening, the prominent intercavernous sinus poses limitations for this approach and may contribute to ...
안정용   +3 more
core   +1 more source

No unfavorable effects on the menstruation recovery of early postoperative hypoprolactinemia after transsphenoidal surgery in patients with lactotroph pituitary neuroendocrine tumor

open access: yesBMC Research Notes
Objective Transsphenoidal surgery for lactotroph pituitary neuroendocrine tumor (PitNET) lowers serum prolactin concentrations, occasionally below the normal range.
Tomohisa Ishida   +4 more
doaj   +1 more source

Transsphenoidal surgery for mixed pituitary gangliocytoma-adenomas

open access: yes, 2017
Background: Most sellar gangliocytomas are discovered with a concurrent pituitary adenoma, also known as a mixed gangliocytoma-adenoma (MGA). MGAs are rare, with fewer than 100 cases reported in the literature to date and only 1 previously documented ...
Ghanim, Daffer   +9 more
core   +1 more source

One-and-a-half nostril endoscopic transsphenoidal approach for pituitary adenomas—a technical report

open access: yesJournal of Otolaryngology - Head and Neck Surgery, 2016
Background Binostril endoscopic transsphenoidal approach (BETA) provides sufficient manipulation space and wide endoscopic vision, although it increases the trauma of nose. Mononostril endoscopic transsphenoidal approach (META) has minimal trauma of nose,
Guodao Wen   +9 more
doaj   +1 more source

Endoscopic and Navigation‐Assisted Middle Fossa Craniotomy for Petrous Apex Cholesterol Granuloma

open access: yes
OTO Open, Volume 10, Issue 1, January-March 2026.
Reef Al‐Asad   +3 more
wiley   +1 more source

Posterior Reversible Encephalopathy Syndrome After Transsphenoidal Surgery for Pituitary Adenoma

open access: yes, 2020
Bilateral, simultaneous, painless vision loss after pituitary adenoma surgery is rare. While iatrogenic causes are most common, failure of cerebral autoregulation may lead to breakdown in blood brain barrier leading to vasogenic edema affecting the ...
Shruthi Harish Bindiganavile; Nita Bhat; Marcus Wong; David Baskin; Andrew Lee
core  

Exoscopic vs. microscopic transsphenoidal surgery for Cushing’s disease: a retrospective single-center study on 388 patients

open access: yes, 2022
Microscopic and endoscopic transsphenoidal surgeries represent the standard treatment for Cushing’s disease (CD). At our institution a new exoscopic approach was implemented.
Aberle, Jens   +8 more
core   +1 more source

OUTCOMES OF ENDOSCOPIC ENDONASAL TRANSSPHENOIDAL SURGERY IN CUSHING'S DISEASE

open access: yes, 2011
Objective: Investigation of differences in the remission and recurrence rates of microadenoma and macroadenoma patients with Cushing's disease following transsphenoidal surgery (TS)
Ozbey, Nese   +5 more
core  

Home - About - Disclaimer - Privacy